Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 15/20 | 1.00 |
| ▸ | MMP3 | P08254 | 7/20 | 1.00 |
| ▸ | MMP2 | P08253 | 7/20 | 1.00 |
| ▸ | MMP9 | P14780 | 7/20 | 1.00 |
| ▸ | MMP1 | P03956 | 6/20 | 1.00 |
| ▸ | MMP7 | P09237 | 4/20 | 1.00 |
| ▸ | MMP8 | P22894 | 4/20 | 1.00 |
| ▸ | MMP13 | P45452 | 4/20 | 1.00 |
| ▸ | MMP14 | P50281 | 4/20 | 1.00 |
| ▸ | ADAM10 | O14672 | 4/20 | 1.00 |
| ▸ | ADAM33 | Q9BZ11 | 2/20 | 0.68 |
| ▸ | MMP15 | P51511 | 1/20 | 0.68 |
| ▸ | MMP16 | P51512 | 1/20 | 0.68 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732231 | 1.00 | ADAM17 (1.00) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL6350418 | 1.00 | ADAM17 (1.00) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL1021287 | 1.00 | ADAM17 (1.00) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL6681213 | 0.93 | ADAM17 (0.86) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL6681788 | 0.91 | ADAM17 (0.84) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL6685255 | 0.91 | ADAM17 (0.84) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL4193352 | 0.90 | ADAM17 (1.00) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL8282217 | 0.90 | ADAM17 (1.00) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL8354979 | 0.90 | ADAM17 (0.82) | ADAM17MMP3MMP2MMP9MMP1 | |
| SCHEMBL4207403 | 0.90 | ADAM17 (0.82) | ADAM17MMP3MMP2MMP9MMP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240156867-A1 | ENGINEERED IMMUNE CELL THERAPEUTICS AND METHODS OF USE | Catamaran Bio, Inc. | 2024-05-16 | — | — | US | disclosed |
| US-20050261762-A1 | Medical devices to prevent or inhibit restenosis | MEDTRONIC VASCULAR, INC. (US) | 2005-11-24 | — | — | US | disclosed |
| WO-2004060212-A1 | ANTI-INFLAMMATORY COATING FOR IMPLANTABLE MEDICAL DEVICES | BRISTOL-MYERS SQUIBB COMPANY (US) | 2004-07-22 | — | — | WO | disclosed |